Offerings // ALNYLAM PHARMACEUTICALS, INC.

ALNY offering history

Every offering-related filing in ALNYLAM PHARMACEUTICALS, INC.’s recent SEC record — registrations (announced capacity) kept separate from pricing documents (executed sales). Reviewed 1,000 filings back to Aug 15, 2014.

Last executed offering
Sep 12, 2025
8-K — priced deal (shares or notes)
Last registration (announced)
Jun 5, 2020
S-3ASR — capacity, not a sale
Executed, last 12 months
1
424B pricings + 8-K 3.02 sales
Registered, last 12 months
0
S-1/S-3/F-series registrations
DateFilingWhat it means
Sep 12, 20258-KEXECUTEDUnregistered share sale disclosed (8-K item 3.02)
Sep 16, 20228-KEXECUTEDUnregistered share sale disclosed (8-K item 3.02)
Jun 5, 2020S-3ASRREGISTEREDAutomatic shelf registration — effective immediately (large filers)
Apr 13, 20208-KEXECUTEDUnregistered share sale disclosed (8-K item 3.02)
Apr 9, 20198-KEXECUTEDUnregistered share sale disclosed (8-K item 3.02)
Jan 15, 2019424B5EXECUTEDShelf takedown priced — shares or notes (small-caps: usually shares; open the filing to confirm)
Jan 14, 2019424B5EXECUTEDShelf takedown priced — shares or notes (small-caps: usually shares; open the filing to confirm)
Nov 14, 2017424B5EXECUTEDShelf takedown priced — shares or notes (small-caps: usually shares; open the filing to confirm)
Nov 13, 2017424B5EXECUTEDShelf takedown priced — shares or notes (small-caps: usually shares; open the filing to confirm)
May 25, 20178-KEXECUTEDUnregistered share sale disclosed (8-K item 3.02)
May 25, 2017424B5EXECUTEDShelf takedown priced — shares or notes (small-caps: usually shares; open the filing to confirm)
May 23, 2017424B5EXECUTEDShelf takedown priced — shares or notes (small-caps: usually shares; open the filing to confirm)
May 5, 2017S-3ASRREGISTEREDAutomatic shelf registration — effective immediately (large filers)
Jan 26, 20158-KEXECUTEDUnregistered share sale disclosed (8-K item 3.02)
Jan 21, 2015424B5EXECUTEDShelf takedown priced — shares or notes (small-caps: usually shares; open the filing to confirm)
Jan 20, 2015424B5EXECUTEDShelf takedown priced — shares or notes (small-caps: usually shares; open the filing to confirm)
ALNY offering-related filings from SEC EDGAR, newest first (capped at 40). Each links to the original document.

Two honest limits. (1) A 424B takedown can price shares or notes— EDGAR’s metadata doesn’t say which, so open the document: large investment-grade filers use these mostly for bond deals (no dilution), small-caps mostly for shares. (2) At-the-market (ATM) programs sell shares gradually and individual sales are not separately filed — the visible footprint is the enabling shelf and its 424B5; actual ATM share counts surface later in the 10-Q/10-K share count. Educational information from public filings, not investment advice.

Is a shelf active now? →Do they need money? →Red flags →Full ALNY workspace →
ALNY offering FAQ

When did ALNY last execute an offering?

Per SEC filings, ALNYLAM PHARMACEUTICALS, INC.'s most recent priced offering document is a 8-K filed 2025-09-12. Note a 424B takedown can price shares or notes (debt) — the linked document says which.

When did ALNY last announce or register an offering?

The most recent registration is a S-3ASR filed 2020-06-05. A registration is capacity to sell shares — not a sale.

Does an offering always mean dilution?

Registered direct offerings and shelf takedowns issue new shares and dilute existing holders. Resale registrations (424B3/B7) let existing holders sell and do not create new shares. Secondary sales by insiders also do not dilute. Each row here is labeled with what it is.